End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28 TWD | +6.46% | +23.89% | +40.00% |
Apr. 15 | Orient Pharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Orient Pharma Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Sales 2022 | 512M 15.85M | Sales 2023 | 890M 27.56M | Capitalization | 4.46B 138M |
---|---|---|---|---|---|
Net income 2022 | -28M -867K | Net income 2023 | 22M 681K | EV / Sales 2022 | 8.44 x |
Net Debt 2022 | 411M 12.72M | Net Debt 2023 | 604M 18.7M | EV / Sales 2023 | 5.69 x |
P/E ratio 2022 |
-136
x | P/E ratio 2023 |
200
x | Employees | 173 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 15.26% |
1 day | +6.46% | ||
1 week | +23.89% | ||
Current month | +15.94% | ||
1 month | +27.85% | ||
3 months | +37.25% | ||
6 months | +38.61% | ||
Current year | +40.00% |
Managers | Title | Age | Since |
---|---|---|---|
Chi Tai Chang
CEO | Chief Executive Officer | - | - |
Chia Ying Chen
DFI | Director of Finance/CFO | - | - |
Meng Lin Tsai
BRD | Director/Board Member | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Cheng Hung Tsai
CHM | Chairman | - | 08-01-14 |
Meng Lin Tsai
BRD | Director/Board Member | - | - |
Wei Chao Kao
BRD | Director/Board Member | - | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-05 | 28 | +6.46% | 889 899 |
24-05-03 | 26.3 | +1.35% | 425,325 |
24-05-02 | 25.95 | +7.45% | 712,983 |
24-04-30 | 24.15 | +0.62% | 263,607 |
24-04-29 | 24 | +6.19% | 329,234 |
End-of-day quote Taipei Exchange, May 05, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
+40.00% | 182M | |
+30.83% | 662B | |
+21.96% | 546B | |
-5.26% | 359B | |
+16.98% | 323B | |
+4.76% | 289B | |
+13.68% | 234B | |
+3.81% | 198B | |
-10.63% | 194B | |
+3.94% | 167B |
- Stock Market
- Equities
- 4166 Stock